![FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is developing a vaccine against the coronavirus, in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder/File Photo](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/E4SRBWT2TGTRRSTWULUPG57HKQ.jpg?smart=true&auth=84fb48354e6419cb5efa3328577f9d3e35643a1a5e58faa7d7fb9af7b04807a9&width=400&height=225)
Britian's AstraZeneca has sold its entie stake in US biotechnology firm Moderna for more than $1bn. Reuters
Britian's AstraZeneca has sold its entie stake in US biotechnology firm Moderna for more than $1bn. Reuters
AstraZeneca sells stake in Covid-19 vaccine maker Moderna for more than $1bn
The British pharmaceutical firm sold its 7.7% holding in the US biotechnology company last year as its shares rose on vaccine breakthrough